Latest Partnerships News

Excite Technology Services reported a strong 53% revenue increase to $12.27 million for FY2025 but also saw its net loss nearly double to $4.44 million. The company expanded its footprint with the acquisition of digital forensics specialist CBIT Pty Ltd.

Papyrus Australia has secured a pivotal contract with UniSA to establish a Rapid Prototyping and R&D facility, advancing its sustainable packaging technology and commercial production plans.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Tamboran Resources has successfully closed the first tranche of its PIPE, raising US$38.7 million to advance its Beetaloo Basin projects, with a second tranche pending shareholder approval.

Emmerson Resources’ joint venture partner Tennant Mining has begun commercial gold production at the Nobles Project near Tennant Creek, setting the stage for potential royalty payments and future development opportunities.

dorsaVi has secured a three-year agreement with SANO Health to deploy its ViSafe+ wearable sensor technology across remote mining sites, reinforcing its foothold in high-risk occupational health sectors.

Beamtree Holdings has forged a strategic alliance with the NHS Confederation to launch a pioneering healthcare analytics platform across UK NHS Trusts, marking a significant step in its international expansion.

Havilah Resources reports significant progress on its copper-gold-cobalt projects Kalkaroo and Mutooroo, alongside promising regional exploration and strategic funding efforts.

Sparc Technologies has entered a strategic collaboration with Detmold Packaging to develop graphene-enhanced paper packaging products that promise improved durability and sustainability.

Cavalier Resources has cleared a key technical hurdle with Raptor Capital completing due diligence on the Crawford Gold Project, paving the way for binding $11 million stream finance negotiations. The updated Pre-Feasibility Study reinforces the project's strong economic potential.

Nanollose Limited has appointed Andrew Moullin as its new CEO and Managing Director, aiming to leverage his extensive commercial expertise to fast-track the company’s microbial cellulose technology towards market readiness.

Dimerix has activated the first clinical trial site in Japan for its pivotal Phase 3 ACTION3 study targeting FSGS, triggering a significant milestone payment from its Japanese partner FUSO Pharmaceutical.